"Mixed" triglyceride breath test: methodological problems and clinical applications.

F. Perri, A. Andriulli

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Laboratory assessment of pancreatic function is unpleasant for the patient and time-consuming for the investigator since it requires duodenal intubation and measurement of maximal pancreatic enzyme output by means of perfusion techniques. Non-invasive indirect tests such as bentiromide test, pancreolauryl test and faecal fat measurement have been introduced in clinical practice but their results depend on the collaboration of the patient in collecting urine or stool. Moreover, faecal fat reflects fat malabsorption but it is neither sensitive nor specific to evaluate exocrine pancreatic function. With the aim to determine whether steatorrhea is due to pancreatic insufficiency, several 14C- (or 13C) breath tests have been developed in which triolein, trioctanoin, tripalmitin, and cholesteryl-octanoate are used as marker substances. In 1989, G. Vantrappen and its group in Leuven developed a breath test in which a new substrate was used: the [1,3-distearyl, 2[carboxyl-13C]octanoyl glycerol] or 13C-"mixed"-triglyceride (MT). The "mixed triglyceride breath test" (MTBT) was shown to be an excellent test of exocrine pancreatic insufficiency when compared with the maximal lipase output after CCK-pancreozymin stimulation. Aim of this paper is to review the methodology of the MTBT and its actual and future applications in clinical practice.

Original languageEnglish
Pages (from-to)99-103
Number of pages5
JournalRevista de Medicina de la Universidad de Navarra
Volume42
Issue number2
Publication statusPublished - 1998

Fingerprint

Breath Tests
Triglycerides
Exocrine Pancreatic Insufficiency
Fats
Triolein
Steatorrhea
Cholecystokinin
Lipase
Intubation
Glycerol
Perfusion
Research Personnel
Urine
Enzymes

Cite this

"Mixed" triglyceride breath test : methodological problems and clinical applications. / Perri, F.; Andriulli, A.

In: Revista de Medicina de la Universidad de Navarra, Vol. 42, No. 2, 1998, p. 99-103.

Research output: Contribution to journalArticle

@article{7c77d92e5ab74a84b28197c3a33c2a6f,
title = "{"}Mixed{"} triglyceride breath test: methodological problems and clinical applications.",
abstract = "Laboratory assessment of pancreatic function is unpleasant for the patient and time-consuming for the investigator since it requires duodenal intubation and measurement of maximal pancreatic enzyme output by means of perfusion techniques. Non-invasive indirect tests such as bentiromide test, pancreolauryl test and faecal fat measurement have been introduced in clinical practice but their results depend on the collaboration of the patient in collecting urine or stool. Moreover, faecal fat reflects fat malabsorption but it is neither sensitive nor specific to evaluate exocrine pancreatic function. With the aim to determine whether steatorrhea is due to pancreatic insufficiency, several 14C- (or 13C) breath tests have been developed in which triolein, trioctanoin, tripalmitin, and cholesteryl-octanoate are used as marker substances. In 1989, G. Vantrappen and its group in Leuven developed a breath test in which a new substrate was used: the [1,3-distearyl, 2[carboxyl-13C]octanoyl glycerol] or 13C-{"}mixed{"}-triglyceride (MT). The {"}mixed triglyceride breath test{"} (MTBT) was shown to be an excellent test of exocrine pancreatic insufficiency when compared with the maximal lipase output after CCK-pancreozymin stimulation. Aim of this paper is to review the methodology of the MTBT and its actual and future applications in clinical practice.",
author = "F. Perri and A. Andriulli",
year = "1998",
language = "English",
volume = "42",
pages = "99--103",
journal = "Revista de Medicina de la Universidad de Navarra",
issn = "0556-6177",
publisher = "Universidad de Navarra",
number = "2",

}

TY - JOUR

T1 - "Mixed" triglyceride breath test

T2 - methodological problems and clinical applications.

AU - Perri, F.

AU - Andriulli, A.

PY - 1998

Y1 - 1998

N2 - Laboratory assessment of pancreatic function is unpleasant for the patient and time-consuming for the investigator since it requires duodenal intubation and measurement of maximal pancreatic enzyme output by means of perfusion techniques. Non-invasive indirect tests such as bentiromide test, pancreolauryl test and faecal fat measurement have been introduced in clinical practice but their results depend on the collaboration of the patient in collecting urine or stool. Moreover, faecal fat reflects fat malabsorption but it is neither sensitive nor specific to evaluate exocrine pancreatic function. With the aim to determine whether steatorrhea is due to pancreatic insufficiency, several 14C- (or 13C) breath tests have been developed in which triolein, trioctanoin, tripalmitin, and cholesteryl-octanoate are used as marker substances. In 1989, G. Vantrappen and its group in Leuven developed a breath test in which a new substrate was used: the [1,3-distearyl, 2[carboxyl-13C]octanoyl glycerol] or 13C-"mixed"-triglyceride (MT). The "mixed triglyceride breath test" (MTBT) was shown to be an excellent test of exocrine pancreatic insufficiency when compared with the maximal lipase output after CCK-pancreozymin stimulation. Aim of this paper is to review the methodology of the MTBT and its actual and future applications in clinical practice.

AB - Laboratory assessment of pancreatic function is unpleasant for the patient and time-consuming for the investigator since it requires duodenal intubation and measurement of maximal pancreatic enzyme output by means of perfusion techniques. Non-invasive indirect tests such as bentiromide test, pancreolauryl test and faecal fat measurement have been introduced in clinical practice but their results depend on the collaboration of the patient in collecting urine or stool. Moreover, faecal fat reflects fat malabsorption but it is neither sensitive nor specific to evaluate exocrine pancreatic function. With the aim to determine whether steatorrhea is due to pancreatic insufficiency, several 14C- (or 13C) breath tests have been developed in which triolein, trioctanoin, tripalmitin, and cholesteryl-octanoate are used as marker substances. In 1989, G. Vantrappen and its group in Leuven developed a breath test in which a new substrate was used: the [1,3-distearyl, 2[carboxyl-13C]octanoyl glycerol] or 13C-"mixed"-triglyceride (MT). The "mixed triglyceride breath test" (MTBT) was shown to be an excellent test of exocrine pancreatic insufficiency when compared with the maximal lipase output after CCK-pancreozymin stimulation. Aim of this paper is to review the methodology of the MTBT and its actual and future applications in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=0032034798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032034798&partnerID=8YFLogxK

M3 - Article

C2 - 10420946

AN - SCOPUS:0032034798

VL - 42

SP - 99

EP - 103

JO - Revista de Medicina de la Universidad de Navarra

JF - Revista de Medicina de la Universidad de Navarra

SN - 0556-6177

IS - 2

ER -